Chymase inhibitor TY-51469 in therapy of inflammatory bowel disease

doi:10.3748/wjg.v22.i5.1826

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8565)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

501

WORD

220

HTML

3663

Figures (1-2)

264

Tables (1-2)

205

Sum=4853

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1161

Download

2551

Sum=3712

Feb 7, 2016 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Feb 7, 2016; 22(5): 1826-1833
Published online Feb 7, 2016. doi: 10.3748/wjg.v22.i5.1826

Full Size Figure Download Figure

Figure 2 Immunohistochemistry staining results in colon tissues from different groups. IL: Interleukin; TGF: Transforming growth factor.

Citation: Liu WX, Wang Y, Sang LX, Zhang S, Wang T, Zhou F, Gu SZ. Chymase inhibitor TY-51469 in therapy of inflammatory bowel disease. World J Gastroenterol 2016; 22(5): 1826-1833
URL: https://www.wjgnet.com/1007-9327/full/v22/i5/1826.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i5.1826